Ftse Mib
34.578,45
-0,29%
DAX
19.486,19
-0,08%
S&P 500
5.815,26
-0,76%
NASDAQ
18.315,59
-1,01%
Bitcoin
67.282,00
0,41%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Astrazeneca Plc (AZN) Astrazeneca Plc (AZN) Notizie

AZN

Astrazeneca (AZN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AZN
DataOraFonteTitoloSimboloCompagnia
14/10/202411:42Alliance NewsAlliance NewsTOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in ChinaLSE:AZNAstrazeneca Plc
07/10/202411:20Alliance NewsAlliance NewsAstraZeneca enters agreement to strengthen cardiovascular pipelineLSE:AZNAstrazeneca Plc
07/10/202410:30RNS Regulatory NewsAstraZeneca PLC AstraZeneca licenses lipid lowering Lp(a) assetLSE:AZNAstrazeneca Plc
07/10/202409:52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails Airsupra trial results to treat asthmaLSE:AZNAstrazeneca Plc
03/10/202412:01Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Calquence gets priority review in USLSE:AZNAstrazeneca Plc
01/10/202416:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
01/10/202410:39Alliance NewsAlliance NewsTOP NEWS: AstraZeneca and Daiichi hail Enhertu priority review in USLSE:AZNAstrazeneca Plc
26/09/202412:00Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails Tagrisso approval in US for cancer formLSE:AZNAstrazeneca Plc
26/09/202408:00RNS Regulatory NewsAstraZeneca PLC Tagrisso US approval in unresectable lung cancerLSE:AZNAstrazeneca Plc
23/09/202409:44Alliance NewsAlliance NewsTOP NEWS: AstraZeneca cancer drug fails to significantly extend livesLSE:AZNAstrazeneca Plc
23/09/202408:05RNS Regulatory NewsAstraZeneca PLC Fasenra recommended for EU approval in EGPALSE:AZNAstrazeneca Plc
23/09/202408:00RNS Regulatory NewsAstraZeneca PLC Final OS results reported for TROPION-Breast01LSE:AZNAstrazeneca Plc
20/09/202420:08Alliance NewsAlliance NewsAstraZeneca gets FDA approval for FluMist self-administrationLSE:AZNAstrazeneca Plc
20/09/202419:00RNS Regulatory NewsAstraZeneca PLC FluMist approved for self-administration in USLSE:AZNAstrazeneca Plc
18/09/202408:00RNS Regulatory NewsAstraZeneca PLC Fasenra EGPA US FDA approvalLSE:AZNAstrazeneca Plc
16/09/202411:05Alliance NewsAlliance NewsTOP NEWS: AstraZeneca celebrates survival rate of Imfinzi-Imjudo mixLSE:AZNAstrazeneca Plc
13/09/202418:00Alliance NewsAlliance NewsDaiichi, Astra's Enhertu shows clinical activity in brain metastasesLSE:AZNAstrazeneca Plc
13/09/202416:15RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
13/09/202412:30Alliance NewsAlliance NewsIN THE KNOW: Deutsche Bank cuts AstraZeneca to 'sell'LSE:AZNAstrazeneca Plc
10/09/202416:28PR Newswire (US)SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy TestingLSE:AZNAstrazeneca Plc
10/09/202412:04IH Market NewsUS Index Futures Drop Amid Economic Report Caution; Oil Prices FallLSE:AZNAstrazeneca Plc
09/09/202423:00Alliance NewsAlliance NewsTOP NEWS: AstraZeneca fails to hit target in lung cancer drug trialLSE:AZNAstrazeneca Plc
05/09/202412:13Alliance NewsAlliance NewsChina probing AstraZeneca employees for potential illegal actsLSE:AZNAstrazeneca Plc
20/08/202409:56Alliance NewsAlliance NewsTOP NEWS: AstraZeneca asthma drug Fasenra gets approval in ChinaLSE:AZNAstrazeneca Plc
19/08/202410:31Alliance NewsAlliance NewsAstraZeneca and Daiichi Sankyo gets US and European nods for EnhertuLSE:AZNAstrazeneca Plc
16/08/202409:27Alliance NewsAlliance NewsAstraZeneca's Infinzi gets US approval for treatment of lung cancerLSE:AZNAstrazeneca Plc
16/08/202408:00RNS Regulatory NewsAstraZeneca PLC Imfinzi approved in US for resectable lung cancerLSE:AZNAstrazeneca Plc
15/08/202409:56Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Imfinzi secures US priority review for cancerLSE:AZNAstrazeneca Plc
14/08/202411:58IH Market NewsU.S. Futures Steady After Tuesday’s Strong Recovery; CPI in FocusLSE:AZNAstrazeneca Plc
14/08/202410:16Alliance NewsAlliance NewsTOP NEWS: AstraZeneca celebrates EU approval of Lynparza plus ImfinziLSE:AZNAstrazeneca Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AZN

La tua Cronologia

BIT
ENI
Eni
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
CPR
Davide Campari
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
TIT
Telecom Italia
BIT
MONC
Moncler
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network